Northern Trust’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
766,255
+497,169
| +185% | +$706K | ﹤0.01% | 3336 |
|
|
2025
Q1 | $412K | Buy |
269,086
+93,911
| +54% | +$144K | ﹤0.01% | 3653 |
|
|
2024
Q4 | $434K | Buy |
175,175
+47,950
| +38% | +$119K | ﹤0.01% | 3704 |
|
|
2024
Q3 | $146K | Sell |
127,225
-393,244
| -76% | -$452K | ﹤0.01% | 3970 |
|
|
2024
Q2 | $573K | Sell |
520,469
-41,755
| -7% | -$45.9K | ﹤0.01% | 3457 |
|
|
2024
Q1 | $697K | Sell |
562,224
-97,413
| -15% | -$121K | ﹤0.01% | 3451 |
|
|
2023
Q4 | $693K | Buy |
659,637
+266
| +0% | +$279 | ﹤0.01% | 3436 |
|
|
2023
Q3 | $4.52M | Buy |
659,371
+9,444
| +1% | +$64.7K | ﹤0.01% | 2511 |
|
|
2023
Q2 | $6.74M | Buy |
649,927
+84,984
| +15% | +$881K | ﹤0.01% | 2323 |
|
|
2023
Q1 | $4.57M | Sell |
564,943
-2,526
| -0.4% | -$20.4K | ﹤0.01% | 2532 |
|
|
2022
Q4 | $8.94M | Buy |
567,469
+13,985
| +3% | +$220K | ﹤0.01% | 2081 |
|
|
2022
Q3 | $8.71M | Buy |
553,484
+29,805
| +6% | +$469K | ﹤0.01% | 2077 |
|
|
2022
Q2 | $7.31M | Buy |
523,679
+53,513
| +11% | +$747K | ﹤0.01% | 2260 |
|
|
2022
Q1 | $8.11M | Sell |
470,166
-19,630
| -4% | -$338K | ﹤0.01% | 2277 |
|
|
2021
Q4 | $7.12M | Sell |
489,796
-11,837
| -2% | -$172K | ﹤0.01% | 2477 |
|
|
2021
Q3 | $9.03M | Buy |
501,633
+45,197
| +10% | +$814K | ﹤0.01% | 2350 |
|
|
2021
Q2 | $8.02M | Buy |
456,436
+347,641
| +320% | +$6.11M | ﹤0.01% | 2526 |
|
|
2021
Q1 | $2.74M | Buy |
108,795
+18,108
| +20% | +$456K | ﹤0.01% | 3081 |
|
|
2020
Q4 | $586K | Sell |
90,687
-5,095
| -5% | -$32.9K | ﹤0.01% | 3685 |
|
|
2020
Q3 | $247K | Sell |
95,782
-2,824
| -3% | -$7.28K | ﹤0.01% | 3770 |
|
|
2020
Q2 | $160K | Sell |
98,606
-256,521
| -72% | -$416K | ﹤0.01% | 3812 |
|
|
2020
Q1 | $370K | Buy |
355,127
+11,275
| +3% | +$11.7K | ﹤0.01% | 3528 |
|
|
2019
Q4 | $650K | Sell |
343,852
-34,442
| -9% | -$65.1K | ﹤0.01% | 3504 |
|
|
2019
Q3 | $409K | Sell |
378,294
-53,168
| -12% | -$57.5K | ﹤0.01% | 3591 |
|
|
2019
Q2 | $945K | Sell |
431,462
-4,119
| -0.9% | -$9.02K | ﹤0.01% | 3376 |
|
|
2019
Q1 | $2.61M | Sell |
435,581
-9,361
| -2% | -$56.1K | ﹤0.01% | 2917 |
|
|
2018
Q4 | $3.29M | Buy |
444,942
+90,791
| +26% | +$671K | ﹤0.01% | 2758 |
|
|
2018
Q3 | $5.14M | Buy |
354,151
+59,118
| +20% | +$858K | ﹤0.01% | 2667 |
|
|
2018
Q2 | $5.89M | Sell |
295,033
-538
| -0.2% | -$10.7K | ﹤0.01% | 2602 |
|
|
2018
Q1 | $5.18M | Buy |
295,571
+4,048
| +1% | +$70.9K | ﹤0.01% | 2563 |
|
|
2017
Q4 | $7.19M | Sell |
291,523
-1,736
| -0.6% | -$42.8K | ﹤0.01% | 2390 |
|
|
2017
Q3 | $7.57M | Buy |
293,259
+37,521
| +15% | +$968K | ﹤0.01% | 2371 |
|
|
2017
Q2 | $6.94M | Buy |
255,738
+87,250
| +52% | +$2.37M | ﹤0.01% | 2414 |
|
|
2017
Q1 | $5.02M | Buy |
168,488
+16,767
| +11% | +$500K | ﹤0.01% | 2548 |
|
|
2016
Q4 | $4.12M | Buy |
151,721
+42,583
| +39% | +$1.16M | ﹤0.01% | 2667 |
|
|
2016
Q3 | $2.8M | Buy |
109,138
+33,430
| +44% | +$856K | ﹤0.01% | 2881 |
|
|
2016
Q2 | $1.4M | Buy |
75,708
+18,357
| +32% | +$339K | ﹤0.01% | 3219 |
|
|
2016
Q1 | $1.09M | Buy |
57,351
+209
| +0.4% | +$3.96K | ﹤0.01% | 3227 |
|
|
2015
Q4 | $1.54M | Buy |
+57,142
| New | +$1.54M | ﹤0.01% | 3173 |
|